An epidemiological study of aplastic anaemia: Relationship of drug exposures to clinical features and outcome

European Journal of Haematology, Supplement

Volumn 57, Issue 60, 1996, Pages 47-52

  Kelly, Judith Parsells ^a,d   Jurgelon, Jan M ^a   Issaragrisil, Surapol ^b   Keisu, Marianne ^c   Kaufman, David W ^a  

^a BOSTON UNIVERSITY   (United States)

^b MAHIDOL UNIVERSITY   (Thailand)

^c Product Safety   (Sweden)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aetiology; Aplastic anaemia; Clinical features; Epidemiology; Prognosis

Indexed keywords

ADOLESCENT; ADULT; AGED; APLASTIC ANEMIA; CHILD; CLINICAL FEATURE; CONFERENCE PAPER; DRUG EXPOSURE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTOPENIA; ARTICLE; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; COMPARATIVE STUDY; EUROPE; ISRAEL; META ANALYSIS; MIDDLE AGED; THAILAND; TREATMENT OUTCOME; UNITED STATES;

ADULT; ANEMIA, APLASTIC; EUROPE; FEMALE; HUMANS; ISRAEL; MALE; MIDDLE AGED; THAILAND; TREATMENT OUTCOME; UNITED STATES;

EID: 0030344665     PISSN: 09024506     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (5)

1. KAUFMAN DW, KELLY JP, LEVY M, SHAPIRO S. The drug etiology of agranulocytosis and aplastic anaemia. New York: Oxford University Press, 1991.
2. KAUFMAN DW, KELLY JP, JURGELON JM, et al. Drugs in the etiology of agranulocytosis and aplastic anaemia. Eur J Haematol 1996 (in press).
3. FLEISS JL. Statistical methods for rates and proportions. New York: Wiley, 1981.
4. BECK WS. Haematology. Cambridge, Massachusetts: The MIT Press, 1991.
5. YOUNG NS, ALTER BS. Aplastic anaemia: acquired and inherited. Philadelphia: WB. Saunders Company, 1994.